A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients

Lamotte, Mark; Annemans, Lieven; Lefever, Aurelia; Nechelput, M; Masure, J.

doi:10.2337/diacare.25.2.303

Public

A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients

Published in Diabetes Care • Feb 1, 2002

Authors:

Mark Lamotte

Lieven Annemans

Aurelia Lefever

Abstract

OBJECTIVES: Obesity is a common condition in type 2 diabetic patients. Treating obesity may enhance hypoglycemic treatment and contribute to the reduction of long-term microvascular and macrovascular complications. Orlistat reduces cardiovascular risk factors in obese type 2 diabetic patients. The o...

Subject

Orlistat

Medicine

Type 2 diabetes

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!